As per our report, the global anatomic pathology market size is predicted to grow from USD 20.60 billion in 2022 to USD 27.77 billion by 2027. The market is forecasted to grow at a CAGR of 6.16% during the forecast period. The use of anatomic pathology with biomarkers in diagnosing cancer positively impacts the market's growth rate.
Anatomic pathology is a diagnostic procedure that examines organs and tissues through macroscopic, microscopic, biochemical, immunologic, and molecular examination. This procedure can help the healthcare professional evaluate quality-based treatment for the patient as it diagnoses accurately.
Anatomic Pathology is a branch of pathology that can be defined as a medicine specialization. The disease's diagnosis is carried out by examining tissues and organs at a microscopic, biochemical, immunological, and macroscopic level. The critical function of anatomy pathology is to detect abnormalities that can help enhance diagnostics and treatment management. Anatomy pathology is most frequently applied to identify different types of tumors and cancers, liver and kidney diseases, infections, and autoimmune disorders. The lines are blurring between the clinical and anatomical pathology due to the technological advancements leading to the overlapping of both branches; procedures like flow cytometry, molecular pathology, and cytogenetics can be performed on both fluid samples and tissue samples.
In clinical centers, anatomic pathology is a technology used to diagnose diseases with microscopic, macroscopic, and other instruments. Modern technologies play a pivotal role in processing, examining, and analyzing cancer diseases and making the right decisions over treatment procedures.
Impact Of COVID-19 On the Anatomic Pathology Market:
COVID-19 outbreak has made drastic changes in every sector, even in the anatomic pathology market. Amid COVID-19, there has been a decrease in hospitals' patient count despite emergency and outpatient services over the past few months. In addition, cancer surgeries are reduced due to the lockdown restrictions. Also, it is estimated that the market will grow enormously once the crisis is normal. According to the world economic forum, 33% of cancer surgeries were postponed in 2020, and around 28 million elective surgeries are planned for next year. Hence, the number of diagnostic procedures also be reduced in 2020 due to the COVID-19 pandemic.
The rising aging population worldwide and increasing incidences of chronic diseases due to changes in food habits and lifestyle are primarily accelerating the global anatomic pathology market.
Growing demand to improve the diagnostic procedures in every clinical center is further propelling the market. Additionally, increasing concern for health and a priority for early diagnosis, a rise in disposable income in urban areas, the adoption of the latest technologies, and the launch of innovative techniques in the medical sector further boost the anatomic pathology market.
Further, the growing prevalence of effective treatment procedures and promoting the patient's well-being after surgeries create chances for the anatomic pathology market to grow. In addition, increasing investments in hospital construction by the government is likely to bolster the demand in the anatomic pathology market.
In 2018, around 9.6 million deaths occurred due to cancer globally, according to the world health organization. The reports also state that cancer risk can be reduced by using proper equipment in the healthcare sector. Market players plan to launch innovative products to gain profits, which is likely to elaborate on its growth rate.
Lack of standardization is slowly hampering the demand of the market. In addition, stringent rules and regulations by the government also negatively impact the growth of the anatomic pathology market.
Market Size Available
2021 to 2027
2022 to 2027
By Product Type, End-User, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
This research report has segmented the global anatomic pathology market based on the product type, end-user, application, and region.
Anatomic Pathology Market - By Product:
Based on product type, Instruments type is leading with the highest shares of the market. Changes in lifestyles and food habits, a rise in the incidences of various health disorders, and growing expenditure on healthcare are majorly elevating the growth of the anatomic pathology market. Furthermore, in the medical sector, there is a growing need to improve diagnostic procedures and analyze the issue with a clear vision to promote effective treatment for the patient, significantly influencing the demand of the market.
Anatomic Pathology Market - By End-User:
Based on the end-user, the diagnostics lab segment contributes the highest shares of the market. Increasing support from both private and public organizations in healthcare centers is accelerating the market's growth. Growing awareness of the availability of various diagnostic procedures for many health disorders is likely to outshine the market's need. In addition, the rise in the number of research institutes in the medical sector is lavishing the growth of the anatomic pathology market.
Anatomic Pathology Market - By Application:
The Lymphoma application accounted for the leading share in the global anatomic pathology market due to the growing adoption of the latest technology in diagnosing and treating the disease. Increasing disposable income, especially in urban areas, is also one of the factors fueling the market's growth. In addition, the growing tendency to launch innovative devices in favor of the end-users is ascribed to bolstering the development of the market. The rise in the revenue in developed and developing countries also magnifies the significant growth rate of the anatomic pathology market.
Anatomic Pathology Market - By Region:
Geographically, the North American anatomic pathology market accounted for the leading share in the global market in 2021. The rise in awareness over the diagnosis procedures is driving the growth of the anatomic pathology industry. Besides, the growing number of research institutes to improve the performance boosts the market's demand. As a result, the U.S. is expected to account for the majority of the share in the North American market during the forecast period.
The APAC anatomic pathology market was right behind the North American market in accounting for the leading share worldwide in 2021 and is predicted to register the fastest CAGR during the forecast period. The growing geriatric population is one of the factors outshining the demand of the business. Also, increasing hospitals' construction with the latest equipment is broadening the growth of the anatomic pathology market.
The Europe anatomic pathology market witnessed the fastest growth rate in the past few years, and it is deemed to have a significant growth rate in the coming years. Acceptance of the latest technologies and implementation of new devices at a high success rate is escalating the European market demand.
The Latin American anatomic pathology market is forecasted to grow at a CAGR of 6.93% from 2022 to 2027.
The anatomic pathology market in the Middle East and Africa is expected to have slight variations in the growth rate.
KEY MARKET PARTICIPANTS:
A few of the noteworthy companies in the global anatomic pathology market profiled in this report are F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, and BISWorld's Pathology Services.
RECENT HAPPENINGS IN THE MARKET:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Diagnostics Lab
5.2.4 Physicians' Office Lab
5.2.5 Y-o-Y Growth Analysis, By End-User
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By End-User
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End-User
22.214.171.124 By Application
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By End-User
220.127.116.11 By Application
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By End-User
188.8.131.52 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 NeoGenomics Laboratories Inc.
8.3 Laboratory Corporation of America Holdings
8.4 Thermo Fisher Scientific
8.5 Quest Diagnostics Incorporated
8.6 Agilent Technologies
8.7 Danaher Corporation
8.8 Sakura Finetechnical Co. Ltd.
8.10 IBISWorld’s Pathology Services
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
As per our research report, the global anatomic pathology market size is estimated to be USD 20.6 billion in 2022 and USD 27.7 billion by 2027.
The global anatomic pathology market is estimated to grow at a CAGR of 6.16% from 2022 to 2027.
Geographically, the North American anatomic pathology market accounted for the largest share of the global market in 2021.
F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, and BISWorld's Pathology Services are some of the prominent companies operating in the global anatomic pathology market.
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.